Literature DB >> 26112869

Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus.

Danielle Trief1, Stacey T Gray2, Frederick A Jakobiec3, Marlene L Durand4, Aaron Fay1, Suzanne K Freitag1, N Grace Lee1, Daniel R Lefebvre1, Eric Holbrook2, Benjamin Bleier2, Peter Sadow2, Alia Rashid3, Nipun Chhabra2, Michael K Yoon1.   

Abstract

BACKGROUND/AIMS: Invasive fungal infections of the head and neck are rare life-threatening infections where prompt diagnosis and intervention is critical for survival. The aim of this study is to determine the clinical characteristics and outcomes of invasive fungal disease of the sinus and orbit, and to compare mucormycosis and Aspergillus infection.
METHODS: A retrospective review was conducted from a single tertiary care eye and ear hospital over 20 years (1994-2014). Twenty-four patients with a confirmed pathological diagnosis of invasive fungal disease of the sinus and/or orbit were identified and their medical records were reviewed. The main outcome measures were type of fungus, location of disease, mortality and visual outcome.
RESULTS: Patients with orbital involvement had a higher mortality and higher likelihood of mucormycosis infection compared with those with sinus-only disease (78.6% vs 20%, p=0.01; 86% vs 30%, p=0.01, respectively). Patients with mucormycosis had a higher mortality (71%) than patients with Aspergillus (29%); however, this was not statistically significant (p=0.16). All patients with orbital involvement and/or mucormycosis infections were immunosuppressed or had inadequately controlled diabetes, and had a cranial neuropathy or ocular motility dysfunction. All five post-transplant patients with orbital infections died, while the two transplant patients with sinus infections survived.
CONCLUSIONS: Patients with orbital fungal infections are more likely to be infected with mucormycosis compared with Aspergillus and have a higher mortality compared with infections sparing the orbit. History of transplant portends a dismal prognosis in orbital infections. Invasive fungal disease should be considered in any immunocompromised patient presenting with a new cranial neuropathy or ocular motility abnormality. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Infection; Orbit

Mesh:

Substances:

Year:  2015        PMID: 26112869     DOI: 10.1136/bjophthalmol-2015-306945

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

Review 1.  Diagnosis and Treatment of Acute Invasive Fungal Sinusitis in Cancer and Transplant Patients.

Authors:  Monica Fung; Jennifer Babik; Ian M Humphreys; Greg E Davis
Journal:  Curr Infect Dis Rep       Date:  2019-11-26       Impact factor: 3.725

2.  Sinonasal Malignancy and Orbital Exenteration Sparing Cancer Surgery.

Authors:  Camilo Reyes; Mihir Patel; C Arturo Solares
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-20

3.  Invasive Fungal Sinusitis Presenting as Acute Posterior Ischemic Optic Neuropathy.

Authors:  Rafat Ghabrial; Arjun Ananda; Sebastiaan J van Hal; Elizabeth O Thompson; Stephen R Larsen; Peter Heydon; Ruta Gupta; Svetlana Cherepanoff; Michael Rodriguez; Gabor Michael Halmagyi
Journal:  Neuroophthalmology       Date:  2017-11-07

4.  Invasive Fungal Sinusitis: Risk Factors for Visual Acuity Outcomes and Mortality.

Authors:  Kristin E Hirabayashi; Oluwatobi O Idowu; Evan Kalin-Hajdu; Catherine E Oldenburg; Frank L Brodie; Robert C Kersten; M Reza Vagefi
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2019 Nov/Dec       Impact factor: 2.011

Review 5.  Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations.

Authors:  Suganthini Krishnan Natesan; Pranatharthi H Chandrasekar
Journal:  Infect Drug Resist       Date:  2016-12-07       Impact factor: 4.003

Review 6.  Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.

Authors:  Matthew W McCarthy; Ruta Petraitiene; Thomas J Walsh
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

7.  Definition and management of invasive fungal rhinosinusitis: a single-centre retrospective study.

Authors:  Gian Luca Fadda; Federica Martino; Giacomo Andreani; Giovanni Succo; Maurizio Catalani; Stefano Di Girolamo; Giovanni Cavallo
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-02       Impact factor: 2.124

8.  Acute Invasive Fungal Rhinosinusitis-Related Orbital Infection: A Single Medical Center Experience.

Authors:  Yu-Fang Huang; Kai-Li Liang; Chiao-Ying Liang; Po-Chin Yang; Jun-Peng Chen; Li-Chen Wei
Journal:  J Ophthalmol       Date:  2021-06-12       Impact factor: 1.909

9.  Bilateral cellulitis caused by invasive aspergillosis associated with bilateral intraorbital abscesses: a case report.

Authors:  Jiahui Wu; Hao Zhou; Ruili Wei; Jinwei Cheng
Journal:  BMC Ophthalmol       Date:  2020-08-15       Impact factor: 2.209

10.  Fluconazole is as effective as other anti-mold agents in preventing early invasive fungal disease after allogeneic stem cell transplantation: assessment of antifungal therapy in haematological disease in China.

Authors:  Yuqian Sun; Jiong Hu; He Huang; Jing Chen; Jianyong Li; Jun Ma; Juan Li; Yingmin Liang; Jianmin Wang; Yan Li; Kang Yu; Jianda Hu; Jie Jin; Chun Wang; Depei Wu; Yang Xiao; Xiaojun Huang
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.